{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:48:00Z","timestamp":1792705680904,"version":"4.5.0"},"reference-count":149,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijo.ijo_1217_18","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T05:29:55Z","timestamp":1542778195000},"page":"1751","source":"Crossref","is-referenced-by-count":97,"title":["Current management of diabetic tractional retinal detachments"],"prefix":"10.4103","volume":"66","author":[{"given":"MichaelW","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DavidJ","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MauriceB","family":"Landers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.245607-1","first-page":"552","article-title":"The prevalence of diabetic retinopathy among adults in the United States","author":"Kempen","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-2","first-page":"937","article-title":"Blindness caused by diabetes \u2013 massachusetts, 1987-1994","author":"Centers","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.4103\/0301-4738.245607-3","first-page":"1796","article-title":"Early treatment diabetic retinopathy study report number 1.Early treatment diabetic retinopathy study research group","author":"Photocoagulation","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-4","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":", Bandello F, Maturi RK, Augustin AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-5","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-77.e35.","DOI":"10.1016\/j.ophtha.2010.02.031"},{"key":"key-10.4103\/0301-4738.245607-6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.245607-9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1006\/pmed.1994.1127","article-title":"Results of 20 years of research on the treatment of diabetic retinopathy","author":"Ferris","year":"1994","journal-title":"Prev Med"},{"key":"key-10.4103\/0301-4738.245607-10","unstructured":"Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings. Ophthalmology 1978;85:82-106."},{"key":"key-10.4103\/0301-4738.245607-11","doi-asserted-by":"crossref","unstructured":"Flynn HW Jr., Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL 3rd, et al. Pars plana vitrectomy in the early treatment diabetic retinopathy study. ETDRS report number 17. The early treatment diabetic retinopathy study research group. Ophthalmology 1992;99:1351-7.","DOI":"10.1016\/S0161-6420(92)31779-8"},{"key":"key-10.4103\/0301-4738.245607-12","first-page":"813","article-title":"Vitrectomy: A pars plana approach","author":"Machemer","year":"1971","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"key-10.4103\/0301-4738.245607-13","unstructured":"Aaberg TM. Vitrectomy for diabetic retinopathy. In: Freeman HM, Hirose T, Schepens CL, editors. Vitreous Surgery and Advances in Fundus Diagnosis and Treatment. New York: Appleton-Century-Crofts; 1977. p. 297-313."},{"key":"key-10.4103\/0301-4738.245607-14","first-page":"210","article-title":"Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment","author":"La","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-15","first-page":"1427","article-title":"Pars plana vitrectomy in the management of blood-induced glaucoma with vitreous hemorrhage","author":"Brucker","year":"1978","journal-title":"Ann Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9394(76)90299-3","article-title":"Ghost cells as a cause of glaucoma","author":"Campbell","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9394(77)90193-3","article-title":"Glaucoma occurring after closed vitrectomy","author":"Campbell","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00414365","article-title":"Elevation of intraocular pressure after pars plana vitrectomy","author":"Weinberg","year":"1976","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-19","first-page":"114","article-title":"Glaucoma after pars plana vitrectomy","author":"Wilensky","year":"1977","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"key-10.4103\/0301-4738.245607-20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0161-6420(85)34014-9","article-title":"Diabetic dense premacular hemorrhage.A possible indication for prompt vitrectomy","author":"O'Hanley","year":"1985","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0161-6420(86)33742-4","article-title":"Timing of vitrectomy for active proliferative diabetic retinopathy","author":"Ramsay","year":"1986","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0161-6420(87)33528-6","article-title":"Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy","author":"Aaberg","year":"1987","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0002-9394(14)70437-4","article-title":", Rubsamen PE.Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane","author":"Harbour","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0161-6420(92)31901-3","article-title":"Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction","author":"Lewis","year":"1992","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"key-10.4103\/0301-4738.245607-26","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.245607-27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00417-005-0141-1","article-title":"Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment","author":"Diederen","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0891-0618(96)00148-2","article-title":"Nitric oxide neurotoxicity","author":"Dawson","year":"1996","journal-title":"J Chem Neuroanat"},{"key":"key-10.4103\/0301-4738.245607-29","first-page":"486386","article-title":"Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous","author":"Dai","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0301-4738.245607-30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archopht.1965.00970040743003","article-title":"Vitreous contraction in proliferative diabetic retinopathy","author":"Davis","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF02148888","article-title":"Microproliferations in proliferative diabetic retinopathy and their relationship to the vitreous: Corresponding light and microscopic studies","author":"Faulborn","year":"1985","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-32","doi-asserted-by":"crossref","unstructured":"Eliott D, Lee MS, Abrams GW. Proliferative diabetic retinopathy: Principles and techniques of surgical treatment. In: Ryan SJ, editor. Retina. 4th ed. Amsterdam, The Netherlands: Elsevier Inc.; 2006. p. 2413-49.","DOI":"10.1016\/B978-0-323-02598-0.50148-8"},{"key":"key-10.4103\/0301-4738.245607-33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archopht.1972.01000020288010","article-title":"Retinal detachment secondary to proliferative diabetic retinopathy","author":"Tasman","year":"1972","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archopht.1987.01060040073036","article-title":"Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment","author":"Thompson","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-35","first-page":"695","article-title":"Retinal breaks in diabetic retinopathy: Vitreoretinal relationships","author":"Kakehashi","year":"1994","journal-title":"Ophthalmic Surg"},{"key":"key-10.4103\/0301-4738.245607-36","first-page":"477","article-title":"Surgical treatment for diabetic retinopathy: 5-year experience","author":"Yang","year":"1998","journal-title":"J Formos Med Assoc"},{"key":"key-10.4103\/0301-4738.245607-37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2337\/diacare.19.12.1445","article-title":"Retinopathy predicts coronary heart disease events in NIDDM patients","author":"Miettinen","year":"1996","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.245607-38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archinte.1989.00390020016004","article-title":"Relation of ocular and systemic factors to survival in diabetes","author":"Klein","year":"1989","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0301-4738.245607-39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0002-9394(01)01124-2","article-title":"Systemic considerations in the management of diabetic retinopathy","author":"Aiello","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9394(83)90331-8","article-title":"Vitrectomy for diabetic rhegmatogenous retinal detachment","author":"Rice","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000079469","article-title":"Medical treatment of retinopathy of type-2 diabetes","author":"Cunha-Vaz","year":"2004","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.245607-42","first-page":"231","article-title":"Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy","author":"Mason","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1442-9071.2005.01013.x","article-title":"Effects of pars plana vitrectomy on retrobulbar haemodynamics in diabetic retinopathy","author":"Sullu","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-44","first-page":"492","article-title":"Diabetic retinopathy vitrectomy study (DRVS) report #1","author":"Two-year","year":"1985","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/bjo.87.3.318","article-title":"Vitrectomy with silicone oil infusion in severe diabetic retinopathy","author":"Castellarin","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-46","unstructured":"Eliott D. Vitreoretinal Attachments in Proliferative Diabetic Retinopathy: Effect on Outcome. Vail Vitrectomy Meeting Vail, CO; 2004."},{"key":"key-10.4103\/0301-4738.245607-47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000355078","article-title":"Macular tractional retinoschisis in proliferative diabetic retinopathy: Clinical characteristics and surgical outcome","author":"Su","year":"2014","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.245607-48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3928\/23258160-20150101-25","article-title":"Stability of macular traction in involutional diabetic retinopathy over a 5-year course","author":"Chao","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.245607-49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0002-9394(80)90012-4","article-title":"Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentation","author":"Meredith","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-50","unstructured":"Charles S. Vitreous Microsurgery. Baltimore: Williams and Wilkins; 2002. p. 107-20."},{"key":"key-10.4103\/0301-4738.245607-51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-9394(21)00235-X","article-title":"\u201cEn bloc\u201d excision of diabetic membranes","author":"Abrams","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0161-6420(89)32813-2","article-title":"Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique","author":"Williams","year":"1989","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0161-6420(94)31255-3","article-title":"A modified en bloc excision technique during vitrectomy for diabetic traction retinal detachment.Results and complications","author":"Han","year":"1994","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(02)01680-X","article-title":"Total en bloc excision: A modified vitrectomy technique for proliferative diabetic retinopathy","author":"Kakehashi","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-55","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0161-6420(95)30895-0","article-title":"Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage","author":"Chaudhry","year":"1995","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ophtha.2004.11.053","article-title":", Lim JI, Chong LP, Chang TS, et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease","author":"Lakhanpal","year":"2005","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/08820538.2013.835847","article-title":"The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage","author":"Berk","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-58","doi-asserted-by":"crossref","unstructured":"Arevalo JF, Sanchez JG, Saldarriaga L, Berrocal MH, Fromow-Guerra J, Morales-Canton V, et al. Retinal detachment after bevacizumab. Ophthalmology 2011;118:2304.e3-7.","DOI":"10.1016\/j.ophtha.2011.05.015"},{"key":"key-10.4103\/0301-4738.245607-59","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/IAE.0000000000000411","article-title":"Comparison of attraction capabilities associated with high-speed, dual-pneumatic vitrectomy probes","author":"Dugel","year":"2015","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00006982-200502000-00015","article-title":"Transconjunctival sutureless 23-gauge vitrectomy","author":"Eckardt","year":"2005","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004397-200404440-00006","article-title":"Diabetic macular edema: A review of past, present, and future therapies","author":"Thompson","year":"2004","journal-title":"Int Ophthalmol Clin"},{"key":"key-10.4103\/0301-4738.245607-62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00417-004-0977-9","article-title":"Surgical treatment of diabetic retinopathy","author":"Helbig","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.icu.0000120676.27548.0e","article-title":"Combining phacoemulsification and vitrectomy in patients with proliferative diabetic retinopathy","author":"Lahey","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-64","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00006982-200509000-00020","article-title":"Heparin-assisted removal of clotting preretinal hemorrhage during vitrectomy for proliferative diabetic retinopathy","author":"Imamura","year":"2005","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-65","first-page":"1","article-title":"Pars plana vitrectomy, phacoemulsification and intraocular lens implantation.Comparison of clinical complications in a combined versus two-step surgical approach","author":"Treumer","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3928\/1542-8877-20050501-07","article-title":"Long-term results of pars plana vitrectomy combined with filtering surgery for neovascular glaucoma","author":"Kono","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.245607-67","first-page":"381","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes 4 years after a trial of intensive therapy","author":"The","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.245607-68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00006982-199111040-00006","article-title":"The use of silicone oil in uveitis and hypotony","author":"Morse","year":"1991","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-69","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9394(87)90176-0","article-title":"Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments","author":"Lucke","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-70","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0161-6420(89)32828-4","article-title":"Silicone oil for the treatment of severe proliferative diabetic retinopathy","author":"Brourman","year":"1989","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02764284","article-title":"Intravitreal silicone oil injection: Complications and treatment of 415 consecutive patients","author":"Riedel","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-72","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/112067210701700614","article-title":"Extended silicone oil tamponade in primary vitrectomy for complex retinal detachment in proliferative diabetic retinopathy: A long-term follow-up study","author":"Shen","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0161-6420(86)33741-2","article-title":"Prognostic indicators of success and failure in vitrectomy for diabetic retinopathy","author":"Thompson","year":"1986","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-74","first-page":"107","article-title":"Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments","author":"La","year":"2001","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00927253","article-title":"Temporary silicone oil tamponade in the treatment of complicated diabetic retinal detachments","author":"Gonvers","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-76","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bjo.77.4.204","article-title":"Removal of silicone oil following diabetic vitrectomy","author":"Pearson","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-77","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00417-004-0912-0","article-title":"A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy","author":"Lane","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0002-9394(75)90864-8","article-title":"Management of cataract in patients undergoing vitrectomy","author":"Peyman","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-79","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0161-6420(89)32842-9","article-title":", Blankenship GW.Posterior chamber intraocular lens implantation during diabetic pars plana vitrectomy","author":"Kokame","year":"1989","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-80","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0161-6420(90)32481-8","article-title":"Extracapsular cataract extraction, posterior chamber lens insertion, and pars plana vitrectomy in one operation","author":"Benson","year":"1990","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-81","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archopht.1990.01070050060031","article-title":"Combined phacoemulsification and pars plana vitrectomy","author":"Koenig","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-82","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00417-005-0146-9","article-title":"Pars plana vitrectomy, phacoemulsification and intraocular lens implantation.Comparison of clinical complications in a combined versus two-step surgical approach","author":"Treumer","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-83","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ophtha.2006.08.017","article-title":"Diabetic vitrectomy: Influence of lens status upon anatomic and visual outcomes","author":"Schiff","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-84","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1097\/IAE.0000000000000171","article-title":"Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes","author":"Silva","year":"2014","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-85","doi-asserted-by":"crossref","unstructured":"Smiddy WE, Feuer W, Irvine WD, Flynn HW Jr., Blankenship GW. Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes. Ophthalmology 1995;102:1688-95.","DOI":"10.1016\/S0161-6420(95)30808-1"},{"key":"key-10.4103\/0301-4738.245607-86","first-page":"1321","article-title":"Clinical application of results of a randomized trial \u2013 Diabetic retinopathy vitrectomy study report 4.The diabetic retinopathy vitrectomy study research group","author":"Early","year":"1988","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-87","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0161-6420(81)34973-2","article-title":"Pars plana vitrectomy for diabetic traction retinal detachment","author":"Aaberg","year":"1981","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-88","unstructured":"Gardner TW, Blankenship GW. Proliferative diabetic retinopathy: Principles and techniques of surgical treatment. In: Ryan SJ, editor. Retina. 2nd ed. St. Louis: Mosby; 1994. p. 515-39."},{"key":"key-10.4103\/0301-4738.245607-89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archopht.1978.03910050009002","article-title":"Four hundred consecutive pars plana vitrectomies with the vitrophage","author":"Peyman","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-90","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0161-6420(80)35115-4","article-title":"Closed vitrectomy in the management of diabetic traction retinal detachment","author":"Tolentino","year":"1980","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-91","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0161-6420(82)34654-0","article-title":"Preoperative prognostic factors in diabetic pars plana vitrectomy","author":"Blankenship","year":"1982","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-92","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(92)90137-I","article-title":"Vitrectomy in the management of diabetic eye disease","author":"Ho","year":"1992","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0002-9394(79)90473-2","article-title":"Clinical results in vitrectomy for diabetic traction retinal detachment","author":"Aaberg","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-94","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0161-6420(02)01291-5","article-title":"Vitrectomy for diabetic traction retinal detachment using the multiport illumination system","author":"Steinmetz","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/IAE.0b013e3181d374a5","article-title":"Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment","author":"Tao","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-96","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/IAE.0000000000000310","article-title":"Diabetic tractional retinal detachment repair by vitreoretinal fellows in a county health system","author":"Rahimy","year":"2015","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-97","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bjo.2007.124495","article-title":"Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy","author":"Yorston","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-98","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bjo.87.5.563","article-title":"Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy","author":"Imamura","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-99","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3928\/1542-8877-19991101-06","article-title":"Perfluoro-N-octane (PFO) in the repair of complicated retinal detachments due to severe proliferative diabetic retinopathy","author":"Maturi","year":"1999","journal-title":"Ophthalmic Surg Lasers"},{"key":"key-10.4103\/0301-4738.245607-100","doi-asserted-by":"crossref","unstructured":"Azen SP, Scott IU, Flynn HW Jr., Lai MY, Topping TM, Benati L, et al. Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology 1998;105:1587-97.","DOI":"10.1016\/S0161-6420(98)99023-6"},{"key":"key-10.4103\/0301-4738.245607-101","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1755-3768.1993.tb04994.x","article-title":"Visual outcome after vitrectomy for diabetic retinopathy.A five-year follow-up","author":"Nakazawa","year":"1993","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"key-10.4103\/0301-4738.245607-102","first-page":"196","article-title":"Vitrectomy for progressive proliferative diabetic retinopathy","author":"de","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archopht.1989.01070010695029","article-title":"Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy","author":"McCuen","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bjo.83.3.261","article-title":"Vitreopapillary traction in proliferative diabetic vitreoretinopathy","author":"Kroll","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/eye.2015.178","article-title":"Spectral domain ocular coherence tomography findings pre- and post vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy","author":"Dooley","year":"2016","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245607-106","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10384-015-0382-4","article-title":"Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy","author":"Murakami","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-107","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/IAE.0b013e318255068a","article-title":"Correlation of outer retinal microstucture and foveal thickness with visual acuity after pars plana vitrectomy for complications of proliferative diabetic retinopathy","author":"Shah","year":"2012","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-108","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000477826","article-title":"Structural changes of the macula on optical coherence tomography after vitrectomy for proliferative diabetic retinopathy","author":"Im","year":"2017","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.245607-109","first-page":"457","article-title":"Long-term results of vitrectomy for complications of proliferative diabetic retinopathy","author":"Ishida","year":"2001","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"key-10.4103\/0301-4738.245607-110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09286580500227068","article-title":"Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy","author":"Soto-Pedre","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"key":"key-10.4103\/0301-4738.245607-111","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ophtha.2003.08.043","article-title":"Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: Ultrasound biomicroscopy findings","author":"Hershberger","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-112","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ophtha.2005.07.010","article-title":"Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: An ultrasound biomicroscopy study","author":"Yeh","year":"2005","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-113","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.icu.0000193098.28798.18","article-title":"Diabetic vitrectomy: Risks, prognosis, future trends","author":"Mason","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-114","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1981.03930010068003","article-title":"The natural history of diabetic extramacular traction retinal detachment","author":"Charles","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-115","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/archopht.1987.01060120077029","article-title":"Vitrectomy for progressive macular traction associated with proliferative diabetic retinopathy","author":"Packer","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-116","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1001\/archopht.1979.01020020338010","article-title":"Retinal wrinkling and macular heterotopia in diabetic retinopathy","author":"Bresnick","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9394(14)75912-4","article-title":"Visual function abnormalities in macular heterotopia caused by proliferative diabetic retinopathy","author":"Bresnick","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-118","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1994.01090230069022","article-title":"Macular heterotopia in proliferative diabetic retinopathy","author":"Michael","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-119","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1442-9071.2004.00845.x","article-title":"Auckland proliferative diabetic vitrectomy fellow eye study","author":"Vote","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjophthalmol-2012-302233","article-title":"Fellow eye vitrectomy for proliferative diabetic retinopathy in an inner city population","author":"Hwang","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-121","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/IAE.0b013e31805d0bfb","article-title":"Outcome of diabetic vitrectomy in Latino population","author":"Flaxel","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-122","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3129\/i08-007","article-title":"Combined rhegmatogenous and traction retinal detachment in proliferative diabetic retinopathy: Clinical manifestations and surgical outcome","author":"Yang","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-123","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3928\/1542-8877-20030701-01","article-title":"Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction\/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy","author":"Douglas","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.4103\/0301-4738.245607-124","first-page":"1653","article-title":"The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachment","author":"Abunajma","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-3768.2008.01420.x","article-title":"Macular appearance after diabetic vitrectomy for fibrovascular proliferation: An optical coherence tomography study","author":"Yang","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00947086","article-title":"Vitrectomy for traction macular detachment in diabetic retinopathy","author":"Meier","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-127","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00417-013-2479-0","article-title":"Clinical and histological features of epiretinal membrane after diabetic vitrectomy","author":"Hsu","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2004.11.035","article-title":"Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction","author":"Gandorfer","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-129","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ophtha.2004.03.035","article-title":"Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy","author":"Itakura","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/eye.2008.334","article-title":"Pars plana vitrectomy for diabetic fibrovascular proliferation with and without internal limiting membrane peeling","author":"Chang","year":"2009","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245607-131","first-page":"29","article-title":"Iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy","author":"Kamura","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-132","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/OPTH.S16414","article-title":"Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy","author":"Issa","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-133","doi-asserted-by":"crossref","unstructured":"Oyakawa RT, Schachat AP, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications. Ophthalmology 1983;90:517-21.","DOI":"10.1016\/S0161-6420(83)34526-7"},{"key":"key-10.4103\/0301-4738.245607-134","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/IAE.0000000000001884","article-title":"All-probe vitrectomy dissection techniques for diabetic tractional retinal detachments: Lift and shave","author":"Berrocal","year":"2018","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-135","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/IAE.0b013e3181853d3c","article-title":"Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment","author":"Altan","year":"2008","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-136","doi-asserted-by":"crossref","unstructured":"Storey PP, Ter-Zakarian A, Philander SA, Olmos de Koo L, George M, Humayun MS, et al. Visual and anatomical outcomes after diabetic traction and traction-rhegmatogenous retinal detachment repair. Retina. 2017 Aug 8. doi: 10.1097\/IAE.0000000000001793. [Epub ahead of print].","DOI":"10.1097\/IAE.0000000000001793"},{"key":"key-10.4103\/0301-4738.245607-137","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.iae.0000225351.87205.69","article-title":"Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy","author":"Chen","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-138","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/IAE.0b013e3181c70168","article-title":"Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy","author":"Hattori","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-139","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2009.07.001","article-title":"Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: A randomized clinical trial","author":"Ahmadieh","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.245607-140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/IAE.0b013e3181a8eb88","article-title":", Bergstrom C, Srivastava SK, Yan J, et al. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin)","author":"Lo","year":"2009","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.245607-141","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","author":"Rizzo","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-142","first-page":"785","article-title":"Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy","author":"di","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-143","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1442-9071.2008.01805.x","article-title":"Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: A prospective case series","author":"Yeoh","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-144","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/eye.2011.149","article-title":"Bevacizumab prior to vitrectomy for diabetic traction retinal detachment","author":"Pokroy","year":"2011","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.245607-145","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","article-title":"Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy","author":"Moradian","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-146","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":", Saravia M, Avery RL, Wu L, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-147","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archophthalmol.2012.1611","article-title":"Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: Report no.1","author":"Sohn","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.245607-148","doi-asserted-by":"crossref","unstructured":"Jiao C, Eliott D, Spee C, He S, Wang K, Mullins RF, et al. Apoptosis and angiofibrosis in diabetic tractional membranes after vascular endothelial growth factor inhibition: Results of a prospective trial. Report no. 2. Retina. 2017 Nov 22. doi: 10.1097\/IAE.0000000000001952. [Epub ahead of print].","DOI":"10.1097\/IAE.0000000000001952"},{"key":"key-10.4103\/0301-4738.245607-149","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ophtha.2008.11.005","article-title":"Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment","author":"Oshima","year":"2009","journal-title":"Ophthalmology"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:34:16Z","timestamp":1786732456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1217_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":149,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"alternative-id":["245607"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1217_18","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}